Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127036682 | 12703668 | 2 | F | 201608 | 20160921 | 20160831 | 20160923 | EXP | US-JNJFOC-20160823505 | JANSSEN | 0.00 | F | Y | 0.00000 | 20160923 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127036682 | 12703668 | 1 | PS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | N | UNKNOWN | 22264 | INJECTION | ||||||||
127036682 | 12703668 | 2 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | Y | N | UNKNOWN | 0 | 1.5 | MG | UNSPECIFIED | BID | ||||
127036682 | 12703668 | 3 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | Y | N | UNKNOWN | 20272 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127036682 | 12703668 | 1 | Schizophrenia |
127036682 | 12703668 | 2 | Schizophrenia |
127036682 | 12703668 | 3 | Schizophrenia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127036682 | 12703668 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127036682 | 12703668 | Blood creatine phosphokinase increased | |
127036682 | 12703668 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127036682 | 12703668 | 2 | 201608 | 0 |